OncoSil Medical Ltd (AU:OSL) has released an update.
OncoSil Medical Ltd has announced a proposed issue of 690 million fully paid ordinary securities, set for November 1, 2024. This move marks a significant capital raising endeavor for the company, potentially boosting its market presence and investor interest. The issuance will be subject to approval and quotation under the ASX listing rules.
For further insights into AU:OSL stock, check out TipRanks’ Stock Analysis page.